Researchers have developed an artificial intelligence platform to detect a range of neurodegenerative disease in human brain tissue samples, including Alzheimer’s disease and chronic traumatic encephalopathy, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published in the Nature medical journal Laboratory Investigation.
You may also like
Does Aspirin Protect Against Hepatocellular Carcinoma in Patients with Chronic HBV Infection?
- March 20, 2019
A population-based study in TaiwanRead more